ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 48 filers reported holding ETON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,460 | +19.5% | 350 | 0.0% | 0.00% | – |
| Q2 2023 | $1,222 | -9.3% | 350 | 0.0% | 0.00% | – |
| Q1 2023 | $1,348 | +36.6% | 350 | 0.0% | 0.00% | – |
| Q4 2022 | $987 | -99.9% | 350 | 0.0% | 0.00% | – |
| Q3 2022 | $735,000 | -19.8% | 350 | 0.0% | 0.00% | – |
| Q2 2022 | $917,000 | -39.9% | 350 | 0.0% | 0.00% | – |
| Q1 2022 | $1,526,000 | -49.8% | 350 | -50.6% | 0.00% | – |
| Q4 2021 | $3,037,000 | -21.2% | 708 | -7.5% | 0.00% | – |
| Q3 2021 | $3,856,000 | -61.7% | 765 | -53.2% | 0.00% | – |
| Q2 2021 | $10,059,000 | -36.4% | 1,633 | -24.4% | 0.00% | – |
| Q1 2021 | $15,804,000 | -34.0% | 2,159 | -26.7% | 0.00% | – |
| Q4 2020 | $23,959,000 | -3.7% | 2,947 | -6.4% | 0.00% | – |
| Q3 2020 | $24,869,000 | +726.8% | 3,148 | +470.3% | 0.00% | – |
| Q2 2020 | $3,008,000 | – | 552 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |